Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors.
Clin Cancer Res
; 26(20): 5358-5367, 2020 10 15.
Article
in En
| MEDLINE
| ID: mdl-32816951
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antigens, Differentiation
/
CTLA-4 Antigen
/
Programmed Cell Death 1 Receptor
/
Antibodies, Monoclonal
/
Neoplasms
Type of study:
Clinical_trials
/
Guideline
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2020
Type:
Article
Affiliation country:
United States